CureVac N.V. (LON:0A9E)
London flag London · Delayed Price · Currency is GBP · Price in USD
3.111
+0.011 (0.36%)
At close: Apr 17, 2025

CureVac Revenue

In the year 2024, CureVac had annual revenue of 535.18M EUR with 895.54% growth. CureVac had revenue of 254.19M in the quarter ending December 31, 2024, with 1,026.36% growth.

Revenue
535.18M EUR
Revenue Growth
+895.54%
P/S Ratio
1.21
Revenue / Employee
544.44K EUR
Employees
983
Market Cap
537.36M GBP

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024535.18M481.42M895.54%
Dec 31, 202353.76M-13.66M-20.26%
Dec 31, 202267.42M-35.57M-34.54%
Dec 31, 2021102.99M54.12M110.74%
Dec 31, 202048.87M31.46M180.61%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 43.19B
Shell 227.10B
HSBC Holdings 48.93B
Unilever 50.25B
Rio Tinto Group 42.86B
RELX PLC 9.43B
British American Tobacco p.l.c. 25.87B
London Stock Exchange Group 8.86B
Revenue Rankings